; Aarkstore Enterprise -Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and Beyond
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Aarkstore Enterprise -Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and Beyond

VIEWS: 55 PAGES: 1

Aarkstore announce a new report " Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and Beyond" through its vast collection of market research report.

More Info
  • pg 1
									Aarkstore Enterprise -

Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and
Beyond

Poland, the largest market in central and eastern Europe, has weathered the global economic
downturn better than many other countries across the continent. Its USD 6+ billion
pharmaceutical sector (at ex-factory prices) in particular has been remarkably resilient, with
value growth in each of the past three years exceeding 9%, the second highest increase in the
EU. Traditionally a market dominated by generics, imported originator brands now account for
72% of sales Yet pricing and reimbursement processes are far from transparent, and if OTCs are
included, patients are asked to pay 68% of the medicines’ bill out-of-pocket, a very high share
for a country with a comprehensive social health insurance system.

Poland is full of surprises. Be better prepared and informed to tackle this dynamic emerging
market. Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and
Beyond will provide you with clear, comprehensive, fully-researched and up-to-date
information, including the following:

      How introductory prices are set.
      The complex forms of reimbursement explained with many illustrative examples.
      Alternatives to appearing on the positive list.
      How manufacturer discounts lessen the co-payment burden and drive market share.
      Therapeutic programmes for high-cost speciality drugs.
      Which products have maximum acquisition prices set for hospitals.
      First 12 months’ experience with AstraZeneca’s direct-to-pharmacy distribution model, the
       only form of exclusive DTP in Europe outside the UK.
      Two-way flow in one of Europe’s newest and fastest-growing parallel trade scenes.
      Reforms to P&R the government is now proposing and what these might mean for the
       pharmaceutical industry.




For more information, please contact :

http://www.aarkstore.com/reports/Pharmaceutical-Pricing-Reimbursement-Distribution-in-Poland-
2010-and-Beyond-44733.html

Contact : Minu

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com
m

								
To top